Step closer to understanding childhood degenerative brain disease

July 3, 2012

(Medical Xpress) -- Researchers at the Australian Institute for Bioengineering and Nanotechnology (AIBN) are a step closer to understanding and combating the degenerative brain disease ataxia-telangiectasia.

As part of a collaborative project, Associate Professor Ernst Wolvetang's AIBN research group has reprogrammed, for the first time, from people with the disease so they can study the effectiveness of potential treatments.

The collaborators are from the Queensland Institute of Medical Research (QIMR) and The University of Queensland's Centre for Clinical Research (UQCCR) led by Professor Martin Lavin.

The reprogramming involves taking skin cells, generating and turning them into for study in the lab.

People with ataxia-telangiectasia develop cancer and brain degeneration because a gene that recognises and repairs is defective.

Associate Professor Wolvetang said the ability to reprogram skin cells from children with ataxia-telangiectasia provided a renewable resource to study the and find medicines to combat it.

“The next step is to correct the genetic mutations in the induced pluripotent stem cellsfrom these patients and then turn these corrected into brain and blood cells and demonstrate these can replace the defective cells that cause the problems in this disease,” Associate Professor Wolvetang said.

“Delivery of such corrected cells, which is still some years away, or novel drugs discovered using the cells generated in this study may help in treating this disease.”

The researchers could start screening medicines in one to two years, but testing in animals would have to be completed before they could be used in humans.

Professor Lavin said the research had benefited from combining his QIMR and UQCCR research group's expertise with that of Associate Professor Wolvetang's AIBN group.

“Joint PhD student Sam Nayler,the support of the patient advocate group BrAshAT, the National Health and Medical Research Council (NHMRC) and a private donor have been instrumental in the success of the project,” Professor Lavin said.

Ataxia-telangiectasia is a rare, inherited disease causing severe disability, including difficulty with movement and coordination, a weakened immune system, a predisposition to infection and a increasing the risk of cancer.

It affects between one in 100,000 and one in 300,000 people.

Patients are frequently in a wheelchair by their early teens and it is generally fatal by the time they reach their twenties.

“I have met patients and their families,” Associate Professor Wolvetang said.

“Witnessing the determination of the children to live life to the full and the heartache borne by their parents, it is self-evident that every effort must be expended to treat these rare diseases.”

The establishment of an Ataxia-telangiectasia Clinic by Dr Kate Sinclair and colleagues at the Royal Children's Hospital and UQCCR has been a great benefit to patient management and for the conduct of these studies.

Details of the skin cell reprogramming from ataxia telangiectasia patients have been published in the journal Stem Translational Medicine.

Explore further: Researchers make breakthrough in stem cell research

More information: View the online publication at stemcellstm.alphamedpress.org/content/early/recent

Related Stories

Researchers make breakthrough in stem cell research

February 13, 2012
(Medical Xpress) -- University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.

Researchers decode a puzzling movement disorder

November 25, 2011
Neurodegenerative diseases represent one of the greatest challenges of our aging society. However, investigation into these diseases is made particularly difficult due to the limited availability of human brain tissue. Scientists ...

Recommended for you

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

As men's weight rises, sperm health may fall

September 20, 2017
(HealthDay)—A widening waistline may make for shrinking numbers of sperm, new research suggests.

New model may help science overcome the brain's fortress-like barrier

September 19, 2017
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.